StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE stock opened at $0.25 on Monday. Ampio Pharmaceuticals has a 1 year low of $0.14 and a 1 year high of $8.30. The firm has a 50-day moving average of $1.14 and a 200 day moving average of $1.83. The company has a market cap of $285,000.00, a P/E ratio of -0.02 and a beta of 1.96.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last posted its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Golden Cross Stocks: Pattern, Examples and Charts
- Hilton Demonstrates Asset Light is Right for Investors
- Why Invest in 5G? How to Invest in 5G Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
